the cliff
Patent cliff
Drugs ranked by the soonest barrier to generic / biosimilar entry. Each row shows the earliest-expiring patent OR FDA exclusivity for that drug — whichever falls first determines when competitive pressure begins.
- Oct 1, 20304.0ypatentAmzeeqminocycline$DERMJourney Medical Corp
- Oct 27, 20304.1ypatentJevtanacabazitaxelSanofi-Aventis US LLC
- Nov 3, 20304.1yNCEKygevvi(doxecitine + doxribtimine)UCB SA
- Nov 13, 20304.2yNCEKomziftiziftomenib$KURAKura Oncology, Inc.
- Nov 18, 20304.2ypatentAkynzeo(fosnetupitant chloride hydrochloride + palonosetron hydrochloride)Helsinn Therapeutics (US) Inc
- Nov 19, 20304.2yNCEHyrnuosevabertinibBayer AG
- Nov 24, 20304.2ypatentEliglustat Tartrateeliglustat tartrateAizant Drug Research Solutions Pvt Ltd
- Dec 1, 20304.2ypatentLanthanum Carbonatelanthanum carbonateBarr Laboratories Inc
- Dec 6, 20304.2ypatentRenvelasevelamer carbonateSanofi-Aventis US LLC
- Dec 14, 20304.2ypatentAXPAXLIaxitinib$OCULOCULAR THERAPEUTIX, INC
- Dec 19, 20304.3yNCEMyqorzoaficamten$CYTKCYTOKINETICS INC
- Dec 30, 20304.3yNCENereustradipitant$VNDAVanda Pharmaceuticals Inc.
- Jan 12, 20314.3yNCEZycubocopper histidinateSentynl Therapeutics Inc
- Jan 14, 20314.3ypatentPliaglis(lidocaine + tetracaine)Taro Pharmaceutical USA Inc
- Jan 19, 20314.3ypatentZypitamagpitavastatin [INN]$MCUJFMEDICURE INC
- Jan 20, 20314.4ypatentPradaxadabigatran etexilate mesylateBoehringer Ingelheim Corp
- Jan 26, 20314.4ypatentInvega Sustennapaliperidone palmitateJohnson & Johnson Innovative Medicine
- Feb 4, 20314.4ypatentVocabriacabotegravir sodiumViiV Healthcare Company
- Mar 2, 20314.5ypatentLevomilnacipran Hydrochloridelevomilnacipran hydrochloridePrinston Pharmaceutical Inc
- Mar 10, 20314.5ypatentBarhemsysamisulpride [INN]Acacia Pharma Group Ltd
- Apr 3, 20314.6ypatentAustedo XRdeutetrabenazineTeva Neuroscience Inc
- Apr 30, 20314.6ypatentYuviwelnavepegritideAscendis Pharma AS
- May 18, 20314.7ypatentSolifenacin Succinatesolifenacin succinateNovadoz Pharmaceuticals LLC
- Jun 11, 20314.7ypatentSunosisolriamfetol hydrochloride$AXSMAxsome Therapeutics, Inc.
- Jul 15, 20314.8ypatentPHENYLEPHRINE HYDROCHLORIDEPHENYLEPHRINE HYDROCHLORIDECaplin Steriles Ltd
- Jul 17, 20314.8ypatentQvar Redihalerbeclomethasone dipropionateTeva Respiratory LLC
- Jul 19, 20314.8ypatentAklieftrifaroteneGalderma Laboratories LP
- Aug 6, 20314.9ypatentEuthyroxlevothyroxine sodiumEMD Serono Inc
- Aug 7, 20314.9ypatentDocivyxdocetaxelMeridian Laboratories Inc
- Aug 8, 20314.9ypatentEcozaeconazole nitrateResilia Pharmaceuticals Inc
- Aug 23, 20314.9ypatentLybalvi(olanzapine + samidorphan l-malate)$ALKSAlkermes plc.
- Sep 6, 20315.0ypatentLynavoylinerixibatGlaxoSmithKline LLC
- Sep 8, 20315.0ypatentFebuxostatfebuxostatNovadoz Pharmaceuticals LLC
- Sep 20, 20315.0ypatentDayvigolemborexantEisai Co Ltd
- Sep 28, 20315.0ypatentVerzenioabemaciclibEli Lilly and Co
- Oct 10, 20315.1ypatentCleviprexclevidipineChiesi USA Inc
- Oct 22, 20315.1ypatentAngeliq(drospirenone + estradiol)Bayer HealthCare Pharmaceuticals Inc
- Oct 25, 20315.1ypatentCoselatrilaciclibPharmacosmos AS
- Oct 31, 20315.1ypatentMytesicrofelemerNapo Pharmaceuticals Inc
- Nov 2, 20315.1ypatentDuobrii(halobetasol propionate + tazarotene)Ortho Dermatologics Inc
- Nov 2, 20315.1ypatentHalobetasol Propionatehalobetasol propionateG&W Laboratories Inc
- Nov 10, 20315.2ypatentUbrelvyubrogepant$ABBVAbbVie Inc.
- Dec 5, 20315.2ypatentALENDRONATE SODIUMALENDRONATE SODIUMIpca Pharmaceuticals Inc
- Dec 19, 20315.3yODE-515Tryngolzaolezarsen sodium$IONSIONIS PHARMACEUTICALS INC
- Jan 3, 20325.3ypatentTuxarin ER(chlorpheniramine maleate + codeine [INN])MainPointe Pharmaceuticals LLC
- Jan 4, 20325.3ypatentDEXMEDETOMIDINE HYDROCHLORIDEDEXMEDETOMIDINE HYDROCHLORIDEHQ Speciality Pharma
- Feb 10, 20325.4ypatentLokelmasodium zirconium cyclosilicateAstraZeneca Pharmaceuticals LP
- Mar 2, 20325.5ypatentNeoprofenibuprofen lysineRecordati Rare Diseases Inc
- Mar 9, 20325.5ypatentAscorascorbic acid [INN]Renovion Inc
- Mar 23, 20325.5ypatentOLINVYKOLICERIDINETrevena Inc
sourced from FDA Orange Book · approved drugs only · biologics + biosimilars excluded (those live in the Purple Book — coming soon)